Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 30, 2025
Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!
GlobeNewswire
·
April 30, 2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a lot of illnesses, and contrary to what people believe, it does not enter the body out of thin air. A person becomes stressed when there is a deficiency of Magnesium in the …
Bioma Probiotics Reviews: Best Probiotic For Gut Health & Weight Loss Ingredients & Side Effects
GlobeNewswire
·
April 30, 2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- In the present health-aware world, probiotics have become a pillar for the upkeep of gut health and general well-being. Among the numerous choices out there, Bioma Probiotic is notable for its …
Cell Counting Market to Hit US$16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 30, 2025
Delray Beach, FL, April 30, 2025 (GLOBE NEWSWIRE) -- The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. …
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
GlobeNewswire
·
April 30, 2025
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …
Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025
GlobeNewswire
·
April 30, 2025
TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (NYSE American: SRXH) (“Better Choice” or the “Company”), a leading global health and wellness company, today announced completing its name change to SRx …
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …
Oncocyte Provides Positive Update on Clinical Trial Progress
GlobeNewswire
·
April 30, 2025
Central Institutional Review Board approved, final preparatory steps underway at first transplant centers Three of the top 10 U.S. transplant centers expected to participate in trial Nearly 10% of annual U.S. transplant volume represented in trial site …
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
GlobeNewswire
·
April 30, 2025
Initial trial phase (“PoC 1”) achieved key learnings and met all study objectives Clinically meaningful pain reduction with 100% of responders achieving zero opioid use at 7 days post-procedure and 73% of responders remaining opioid free at 4-6 week follow …
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
GlobeNewswire
·
April 30, 2025
— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …
Cellectar Announces Plan to Explore Strategic Alternatives
GlobeNewswire
·
April 30, 2025
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
GlobeNewswire
·
April 30, 2025
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Folia Health and Inspire are Partnering to Bring Personalized Home Health Observations to the Forefront of Patient Focused Drug Development Research
GlobeNewswire
·
April 30, 2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Folia Health, the pioneer of patient-driven Home Reported Outcomes (HRO), has partnered with Inspire, the world's leading online health community and real-world data platform, to uniquely empower patients and …
TrainingPros Named a 2025 Top 20 Staffing and Temporary Resources Company by Training Industry
EIN Presswire
·
April 30, 2025
TrainingPros, a leading provider of contract staffing for (L…
BioAtla to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
GlobeNewswire
·
April 30, 2025
DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a. …
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences: Event: BofA …
Solid Biosciences to Participate at The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, …
Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academy of Ophthalmology’s Eyecelerator Conference and the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
GlobeNewswire
·
April 30, 2025
BERKELEY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its president and chief scientific officer, Wesley Jackson, Ph.D., will present a company and …
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
GlobeNewswire
·
April 30, 2025
WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced …